dr. kumar on tourmaline-mm1 study for multiple myeloma
Published 8 years ago • 215 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:55
dr. moreau on tourmaline-mm1 study for multiple myeloma
-
1:56
dr. kumar discusses study of ixazomib in multiple myeloma
-
1:04
dr. kumar on ixazomib combo for multiple myeloma treatment
-
1:32
dr. kumar on the rationale for studying venetoclax in multiple myeloma
-
1:24
dr. kumar on properly managing patients with multiple myeloma
-
1:50
dr. kumar on the management of newly diagnosed patients with multiple myeloma
-
2:21
overview of the tourmaline-mm1 study in relapsed/refractory multiple myeloma
-
1:17
dr. kumar on defining multiple myeloma
-
0:49
dr. kumar discusses ixazomib in multiple myeloma
-
1:50
dr. kumar discusses advances in the field of multiple myeloma
-
2:21
tourmaline-mm1 study produces optimistic results for mm
-
5:29
tourmaline-mm1: benefit of ird triplet for r/r mm
-
8:07
eu approval of ixazomib for relapsed/refractory myeloma
-
10:55
patient selection for ixazomib in myeloma
-
7:15
endeavour, aspire and tourmaline-mm1 trial results for multiple myeloma
-
3:55
ixazomib benefit persists despite prior therapy in tourmaline-mm1 subset analysis
-
7:45
goals of therapy in multiple myeloma
-
6:52
ixazomib extends pfs in the tourmaline-mm1 trial
-
7:11
final analysis of the phase 3 tourmaline-mm1: ixazomib lenalidomide-dex vs placebo-rd in rrmm